BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23810275)

  • 1. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.
    Teich N; Klugmann T
    J Crohns Colitis; 2014 Jan; 8(1):85-6. PubMed ID: 23810275
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
    Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
    J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for treatment of pyoderma gangrenosum with ulcerative colitis.
    Joob B; Wiwanikit V
    J Crohns Colitis; 2013 May; 7(4):e153. PubMed ID: 22981616
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
    López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
    Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab.
    De la Morena F; Martín L; Gisbert JP; Fernández Herrera J; Goiriz R
    Inflamm Bowel Dis; 2007 Apr; 13(4):509-10. PubMed ID: 17206663
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
    Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
    Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
    Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
    Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
    Baglieri F; Scuderi G
    Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
    Cocco A; Angelucci E; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Dr. Joob et al.'s letter.
    Andrisani G; Armuzzi A
    J Crohns Colitis; 2013 May; 7(4):e154. PubMed ID: 23040291
    [No Abstract]   [Full Text] [Related]  

  • 13. A large shin ulcer after minor trauma: please do not debride!
    Williamson KD; Nguyen NQ
    Gastroenterology; 2012 Oct; 143(4):e11-2. PubMed ID: 22921665
    [No Abstract]   [Full Text] [Related]  

  • 14. Refractory pyoderma gangrenosum treated with infliximab in an infant.
    Campos-Muñoz L; Conde-Taboada A; Aleo E; Toledano E; López-Bran E
    Clin Exp Dermatol; 2014 Apr; 39(3):336-9. PubMed ID: 24635074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis with refractory pyoderma gangrenosum.
    Liu FC; Liu NT; Huang TY
    QJM; 2020 Aug; 113(8):567-568. PubMed ID: 32129869
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
    Castro-Fernández M; Sánchez-Muñoz D; Ruíz-Granados E; Merchante N; Corzo J
    Am J Gastroenterol; 2007 Dec; 102(12):2865-6. PubMed ID: 18042124
    [No Abstract]   [Full Text] [Related]  

  • 17. Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis.
    Botros N; Pickover L; Das KM
    Gastroenterology; 2000 Apr; 118(4):654, 809. PubMed ID: 10777349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infliximab for a girl with refractory pyoderma gangrenosum].
    Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis].
    Lorincz M; Kleszky M; Szalóki T; Szalóki T
    Orv Hetil; 2010 Jan; 151(4):144-7. PubMed ID: 20071320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
    Sinagra E; Orlando A; Renna S; Maida M; Cottone M
    Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.